Quality Care
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
The company will use the funds to broaden its product line and boost recruitment.
Dr. Srinivasan Suresh says the hospital implements AI tools slowly and responsibly, and only if they are brought forth by a clinician, which ensures they meet real clinical needs and can secure staff buy-in.
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.
Pharmacies can automate patient communications, enhance medication adherence and decrease operational pressure.
Karthik Raja, Ascension's chief analytics and AI officer, says that AI success demands dual goals: pursue inspiring moonshots, but start with "quick wins" that solve daily pain points and drive efficiencies.
AI can do more than analyze data, according to the American College of Cardiology's Dr. Ami Bhatt; it can act as an adjunct to human care, boosting safety, surfacing insights and giving patients more agency.
Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.
Also, health IT company UCrest from Malaysia has received its first patent for its AI-powered digital platform from Taiwan.
Clarity uses video and audio to examine facial expressions and identify intimidating gestures and aggressive language.